Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

S*BIO Pte Ltd Company Profile

10:46 EDT 29th July 2014 | BioPortfolio

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization.


News Articles [602351 Results]

Beyond the Crisis

First published in 1994, this volume discusses the nature of health care reform and the capacity for medical excellence within the context of such reform.

Science-Based Economic Development

Key elements in science-based development.

MEN1, The Gene For Multiple Endocrine Neoplasia Type 1

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant familial cancer syndrome characterized by occurrence of tumors in parathryroids, enteropancreatic endocrine tissues, the an...

Genetic Polymorphisms Of Interleukin-1 Alpha And Beta Associated With Early Onset Periodontitis

Periodontal disease occurs in 10-20% of adults, and constitutes a major cause of tooth loss. About 0.5% of U.S. adolescents between the ages of 14 to 17 years old (about 70,000) have localize...

The Application Of Induction Tolerance By Oral Feeding Of Myelin Basic Protein To The Generation Of Increased Resistance To Stroke

In vivo experiments have shown that immunosuppression in the brain can be achieved through oral tolerance to myelin basic protein (MBP). Following exposure to MBP, immune cells are relatively...

Use of Constitutive Transport Elements to Control the Host Range of Retroviral Vectors

The major host range determinant for retroviruses and for retroviral vectors is the envelope glycoprotein. However there is a second element, the constitutive transport element, or CTE, that...

Mouse Models For Huntington's Disease

Huntington's Disease (HD) is one of a number of neurological diseases in which excessive repetition of the CAG nucleotide sequence, which codes for glutamines, causes an abnormally shaped HD...

Calcium Channel Compositions and Methods of Use Thereof

This invention described in this patent application relates to the identification, isolation and cloning of a three cDNAs identified during a search of the short arm of chromosome 3 for a tum...

Clinical Trials [66371 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Companies [46758 Results]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

OurPaths

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Schiff Nutrition International, Inc.

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...

More Information about "S*BIO Pte Ltd" on BioPortfolio

We have published hundreds of S*BIO Pte Ltd news stories on BioPortfolio along with dozens of S*BIO Pte Ltd Clinical Trials and PubMed Articles about S*BIO Pte Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of S*BIO Pte Ltd Companies in our database. You can also find out about relevant S*BIO Pte Ltd Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topics

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record